Panel Supports Medtronic Implant

FDA's Orthopedic and Rehabilitation Devices Panel voted 6-5 in favor of Medtronic's new Amplify spinal implant. The device is designed to stimulate bone growth in patients who have had spinal surgery.

July 29, 2010

1 Min Read
Panel Supports Medtronic Implant

Last week FDA voiced concerns about the number of cancer cases seen among patients treated with the Amplify, which uses a protein called recombinant bone morphogenetic protein-2, or rhBMP-2, to promote bone growth. Although FDA is not required to follow the recommendation of the panel, it usually does.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like